• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Creso to Distribute Swiss Cannabis in Asia and LATAM

June 1, 2017

 

Earlier today, ASX Listed cannabis company, Creso Pharma announced that they have signed an LOI with Swiss medicinal cannabis producer, Cannapharm AG to distribute Cannapharm products in the Asia Pacific and LATAM regions. The agreement initially covers seven countries; Australia, New Zealand, China, Brazil, Chile, Columbia and Mexico but can be expanded to include other countries and/or regions. 

 

Co-Founder and Group CEO of Creso Pharma Ltd., Dr. Miri Halperin Wernli had this to say about the agreement...

 

"This partnership with Cannapharm significantly builds on our position within the Australian market as a leading medicinal cannabis company that intends to supply the Australian market with high quality medicinal cannabis products. Cannapharm is the perfect partner and strategic fit for Creso given their expertise in the cultivation, manufacture and distribution of cannabis derived therapeutic products."

 

Remember, because the first cultivation license in Australia was just granted earlier this week to Cann Group Ltd. (ASX:CAN), at the moment all legal medical cannabis products are produced elsewhere and imported to Australia

 

About Cannapharm

 

Cannapharm is a Swiss-based producer of medical marijuana, that is authorized by the Swiss Federal Office of Public Health and the Swiss Agency for Therapeutic Products to cultivate, breed, manufacture and distribute wholesale cannabis and cannabis products. 

 

The company produces product in accordance with the requirements of Good Agricultural Practice (GAP) and does not use chemical crop protection products. 

 

Market Reaction

 

On this news, shares of CPH surged 3.80% closing Thursday's trading on the ASX at $0.41 AUD. Year to date, shares of Creso Pharma are up nearly 75%.  

 

View the original ASX Announcement here

 

Conclusion 

 

We're expanding our coverage of the marijuana industry in Australia, Switzerland and beyond as it continues to blossom in many places across the globe. To stay up to date, be sure to subscribe to our Australian Cannabis newsletter and check out our Australian marijuana news section. Check back soon for more coverage on Switzerland. Also, don't forget to connect with The Daily Marijuana Observer on Facebook, Twitter, and Instagram

 

D/M/O

 

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.